Viewing Study NCT07333066

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2026-03-26 @ 3:15 PM

Ignite Modification Date: 2026-03-30 @ 10:19 PM

Study NCT ID: NCT07333066

Status: NOT_YET_RECRUITING

Last Update Posted: 2026-01-12

First Post: 2025-12-30

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module